Krystal Biotech buy Chardan Capital
Start price
12.12.24
/
50%
€165.85
Target price
12.12.25
€201.99
Performance (%)
-14.77%
Price
10:38
€141.35
Summary
This prediction is currently active. The prediction for Krystal Biotech disappoints with a performance of -14.77%. This prediction currently runs until 12.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 5.851% | 5.851% |
| iShares Core DAX® | -0.560% | -3.108% |
| iShares Nasdaq 100 | 1.622% | 4.701% |
| iShares Nikkei 225® | 1.807% | 5.094% |
| iShares S&P 500 | 0.859% | 2.906% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat